You are here
Biomarkers and Diagnostics
Diagnostic, prognostic and predictive biomarkers and diagnostic tools and methods are available for licensing and/or collaborative development.
The integrin avß6 is an exciting emerging target for both imaging and therapy across many common tumour types including pancreatic, breast, oesophagus, head and neck, skin, lung and ovarian.
Read moreThe Tyrer-Cuzick model is a breast cancer risk assessment tool incorporating family history, endogenous hormonal factors, benign disease, risk factors such as age and body mass index, as well as ge
Read more